Insider Transactions in Q1 2025 at Corcept Therapeutics Inc (CORT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2025
|
Hazel Hunt Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,176
-31.71%
|
$5,791,968
$68.11 P/Share
|
|
Feb 11
2025
|
Hazel Hunt Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+35.84%
|
$450,000
$3.29 P/Share
|
|
Feb 10
2025
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$149,600
$68.08 P/Share
|
|
Feb 10
2025
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Feb 03
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-36.34%
|
$330,000
$66.92 P/Share
|
|
Feb 03
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.58%
|
$60,000
$12.46 P/Share
|
|
Feb 03
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-18.99%
|
$1,320,000
$66.92 P/Share
|
|
Feb 03
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.02%
|
$80,000
$4.47 P/Share
|
|
Jan 27
2025
|
James N Wilson |
SELL
Bona fide gift
|
Indirect |
7,800
-0.54%
|
-
|
|
Jan 22
2025
|
James N Wilson |
BUY
Other acquisition or disposition
|
Indirect |
146,742
+9.17%
|
-
|
|
Jan 22
2025
|
James N Wilson |
SELL
Bona fide gift
|
Direct |
146,742
-100.0%
|
-
|
|
Jan 22
2025
|
James N Wilson |
SELL
Payment of exercise price or tax liability
|
Direct |
103,258
-41.3%
|
$6,092,222
$59.03 P/Share
|
|
Jan 22
2025
|
James N Wilson |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+50.0%
|
$750,000
$3.29 P/Share
|
|
Jan 10
2025
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$110,000
$50.54 P/Share
|
|
Jan 10
2025
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Jan 03
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+11.59%
|
$9,111
$3.29 P/Share
|
|
Jan 02
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-18.99%
|
$1,000,000
$50.39 P/Share
|
|
Jan 02
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+15.96%
|
$60,000
$3.88 P/Share
|
|
Jan 02
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-36.34%
|
$250,000
$50.39 P/Share
|
|
Jan 02
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+26.65%
|
$55,000
$11.35 P/Share
|
|
Jan 02
2025
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,000
-35.35%
|
$550,000
$50.5 P/Share
|
|
Jan 02
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.12%
|
$33,000
$3.29 P/Share
|
|
Jan 01
2025
|
G Leonard Baker Jr Director |
SELL
Bona fide gift
|
Indirect |
0
|
-
|